Immunic, Inc. (IMUX) vs Unicycive Therapeutics, Inc. (UNCY)
- Immunic, Inc. IMUX 6.97 −1.83%
- Unicycive Therapeutics, Inc. UNCY 3.36 −6.41%
Immunic, Inc. and Unicycive Therapeutics, Inc. are both Biotechnology companies. Immunic, Inc. and Unicycive Therapeutics, Inc. are of similar size ($100.0M and $96.9M). Across the 8 metrics below, Unicycive Therapeutics, Inc. leads on 5 and Immunic, Inc. on 3.
Valuation
Profitability
| Metric | IMUX | UNCY | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (138.17%) | (101.07%) | (56.36%) |
| Return on assets | (101.15%) | (69.05%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack